Evidence map›Paper›PMID 34210195›Full record

ReviewThe neuroradiology journal2021

Bioactive refinement for endosaccular treatment of intracranial aneurysms.

Zoltan Szatmary, Jérémy Mounier, Kevin Janot, Jonathan Cortese, Claude Couquet, Frédéric Chaubet, Ramanathan Kadirvel, Sylvia M Bardet, Charbel Mounayer, Aymeric Rouchaud

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The neuroradiology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Zoltan SzatmaryDepartment of Radiology, Dupuytren Hospital, Limoges University, France.ORCID https://orcid.org/0000-0002-2543-6535
Jérémy MounierXLIM UMR CNRS No. 7252, Limoges University, France.
Kevin JanotXLIM UMR CNRS No. 7252, Limoges University, France.
Jonathan CorteseXLIM UMR CNRS No. 7252, Limoges University, France.
Claude CouquetXLIM UMR CNRS No. 7252, Limoges University, France.
Frédéric ChaubetLaboratory for Vascular Translational Science, UMRS 1148, INSERM, Université de Paris, France.
Ramanathan KadirvelMayo Clinic Rochester, Radiology, USA.
Sylvia M BardetXLIM UMR CNRS No. 7252, Limoges University, France.ORCID https://orcid.org/0000-0002-0217-6910
Charbel MounayerDepartment of Radiology, Dupuytren Hospital, Limoges University, France.
Aymeric RouchaudDepartment of Radiology, Dupuytren Hospital, Limoges University, France.
Centre National de la Recherche Scientifique · FRInserm · FRMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endovascular treatment is the first-line therapy for most intracranial aneurysms; however, recanalisation remains a major limitation. Developments in bioengineering and material science have led to a novel generation of coil technologies for aneurysm embolisation that address clinical challenges of aneurysm recurrence. This review presents an overview of modified surface coil technologies and summarises the state of the art regarding their efficacy and limitations based on experimental and clinical results. We also present potential perspectives to develop biologically optimised devices.

Indexed as

Embolization, TherapeuticIntracranial AneurysmHumansTreatment Outcomebioactivebiological optimisationcoilsendovascular treatmenthealingIntracranial aneurysmreview

Identifiers

PMID34210195
PMCPMC8649181
OpenAlexW3177047707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.